Rising demand for effective treatments, and strong R&D investments to support pipeline candidates are expected to drive Dry Eye Syndrome market growth....
Reports Total Revenues of $3.92 Billion; U.S. GAAP Net Earnings of $264 Million; Adjusted EBITDA of $1.31 Billion; U.S. GAAP Net Cash Provided by Operating...
/PRNewswire/ -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...
The increasing use of contact lenses has resulted in a higher incidence of dry eyes, leading to a rise in demand for specialized products that protect and...
/PRNewswire/ -- The "Dry Eye Syndrome Treatment - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Indication, By Product...
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SAN DIEGO & VANCOUVER, British Columbia — Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based…
/PRNewswire/ -- The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc....